Javascript must be enabled to continue!
Xinfeng capsule inhibits cartilage extracellular matrix degradation and inflammation in osteoarthritis by modulating circ_0032131 and miR-502-5p/TRAF2 axis
View through CrossRef
Abstract
Clinical practice has proved that Xinfeng capsule (XFC) can effectively cure osteoarthritis (OA). In our study, we investigated the molecular mechanism and role of XFC in the treatment of OA using network pharmacology and cellular experiments. hsa_circ_0032131 was overexpressed in OA peripheral blood mononuclear cells (PBMCs). Both PBMCs and chondrocytes are cellular members of the inflammatory microenvironment in OA. To investigate the function of hsa_circ_0032131 in PBMCs stimulated chondrocytes. A series of functional experiments revealed the relationship between hsa_circ_0032131 and the miR-502-5p/TRAF2 axis. To further determine whether XFC might treat OA through the interaction of circ_0032131 with the miR-502-5p/TRAF2 axis. CKK-8 assay and flow cytometry were conducted to detect the proliferation and apoptosis process of XFC-treated cells. Multiple experimental methods were utilized to detect the expression levels of inflammatory factors, extracellular matrix, and so on. The results demonstrated that the expression of hsa_circ_0032131 was obviously elevated in PBMCs of OA patients and correlated with clinical immuno-inflammatory factors and ECM indexes. Network pharmacology verified that the chief active ingredients of XFC exerted their roles mainly in the regulation of inflammation (IL1A, IL1B, IL4), extracellular matrix metabolism (MMP13, COL2A1), and tumour necrosis factor (TNF, TRAF2). In vitro experiments revealed that knockdown of circ_0032131 in PBMCs-stimulated chondrocytes inhibited apoptosis, inflammation and ECM degradation. Circ_0032131 was verified as a sponge of miR-502-5p by targeting, and TRAF2 was a direct target of miR-502-5p. In addition, rescue experiments verified that XFC blocked the effects of hsa_circ_0032131 overexpression on extracellular matrix, inflammation and cell viability. XFC has a favorable anti-inflammatory effect on OA, and its molecular mechanism was preliminarily elucidated.
Title: Xinfeng capsule inhibits cartilage extracellular matrix degradation and inflammation in osteoarthritis by modulating circ_0032131 and miR-502-5p/TRAF2 axis
Description:
Abstract
Clinical practice has proved that Xinfeng capsule (XFC) can effectively cure osteoarthritis (OA).
In our study, we investigated the molecular mechanism and role of XFC in the treatment of OA using network pharmacology and cellular experiments.
hsa_circ_0032131 was overexpressed in OA peripheral blood mononuclear cells (PBMCs).
Both PBMCs and chondrocytes are cellular members of the inflammatory microenvironment in OA.
To investigate the function of hsa_circ_0032131 in PBMCs stimulated chondrocytes.
A series of functional experiments revealed the relationship between hsa_circ_0032131 and the miR-502-5p/TRAF2 axis.
To further determine whether XFC might treat OA through the interaction of circ_0032131 with the miR-502-5p/TRAF2 axis.
CKK-8 assay and flow cytometry were conducted to detect the proliferation and apoptosis process of XFC-treated cells.
Multiple experimental methods were utilized to detect the expression levels of inflammatory factors, extracellular matrix, and so on.
The results demonstrated that the expression of hsa_circ_0032131 was obviously elevated in PBMCs of OA patients and correlated with clinical immuno-inflammatory factors and ECM indexes.
Network pharmacology verified that the chief active ingredients of XFC exerted their roles mainly in the regulation of inflammation (IL1A, IL1B, IL4), extracellular matrix metabolism (MMP13, COL2A1), and tumour necrosis factor (TNF, TRAF2).
In vitro experiments revealed that knockdown of circ_0032131 in PBMCs-stimulated chondrocytes inhibited apoptosis, inflammation and ECM degradation.
Circ_0032131 was verified as a sponge of miR-502-5p by targeting, and TRAF2 was a direct target of miR-502-5p.
In addition, rescue experiments verified that XFC blocked the effects of hsa_circ_0032131 overexpression on extracellular matrix, inflammation and cell viability.
XFC has a favorable anti-inflammatory effect on OA, and its molecular mechanism was preliminarily elucidated.
Related Results
Chinese herbal compound Xinfeng capsule inhibits cartilage extracellular matrix degradation and inflammation in osteoarthritis by modulating circ_0032131 and the miR-502-5p/TRAF2 axis
Chinese herbal compound Xinfeng capsule inhibits cartilage extracellular matrix degradation and inflammation in osteoarthritis by modulating circ_0032131 and the miR-502-5p/TRAF2 axis
Abstract
Objective
We intended to explore the anti-inflammatory and chondroprotective effects of Xinfeng capsule (XFC) in osteoarthritis (OA), perhaps through the regulati...
GW24-e2497 Circulating MicroRNAs as Potential Biomarkers of Coagulation Dysfunction in Patients with Vulnerable Coronary Artery Disease
GW24-e2497 Circulating MicroRNAs as Potential Biomarkers of Coagulation Dysfunction in Patients with Vulnerable Coronary Artery Disease
Objectives
The activation of coagulation and fibrinolysis plays a critical role in the incidence of coronary events. MicroRNAs (miRNAs) are small non-coding ribon...
Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
AbstractMicroRNAs are a class of non‐coding molecules found to regulate a variety of cellular functions in health and disease. Dysregulation of microRNAs is involved in liver disea...
MicroRNAs Expression Profile in Young Patients with Acute Myocardial Infarction
MicroRNAs Expression Profile in Young Patients with Acute Myocardial Infarction
Introduction: Acute myocardial infarction (AMI) is a severe coronary heart disease. Targeted miRNAs studies implicated two main pathways in the regulation of AMI namely pro-apopt...
MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
Abstract
Background
MicroRNAs (miRNAs) can function as either oncogenes or tumor suppressor genes via regulation of cell proliferation and/or apo...
A Systematic Evidence‐Based Review Regarding miRNA Polymorphisms in Recurrent Implantation Failure
A Systematic Evidence‐Based Review Regarding miRNA Polymorphisms in Recurrent Implantation Failure
ABSTRACT
Background
This systematic review aimed to evaluate whether specific single nucleotide polymorphisms (SNPs) in m...
Osteoarthritis in the Middle-Aged and Elderly in China: Prevalence and Influencing Factors
Osteoarthritis in the Middle-Aged and Elderly in China: Prevalence and Influencing Factors
Background: Osteoarthritis is a common joint disease, with the acceleration of the aging process in China, it has troubled the middle-aged and elderly. There have been some epidemi...
Abstract B41: Specific blocking of miR-17-5p guide strand in triple negative breast cancer cells, without amplifying passenger strand activity
Abstract B41: Specific blocking of miR-17-5p guide strand in triple negative breast cancer cells, without amplifying passenger strand activity
Abstract
Conventional wisdom holds that only one of the two strands in a microRNA (miRNA) precursor duplex is selected as the active guide strand. The complementary ...

